(NASDAQ: GOVX) Geovax Labs's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 24.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.69%.
Geovax Labs's earnings in 2026 is -$21,369,041.On average, 4 Wall Street analysts forecast GOVX's earnings for 2026 to be -$61,820,555, with the lowest GOVX earnings forecast at -$75,734,434, and the highest GOVX earnings forecast at -$46,133,576. On average, 3 Wall Street analysts forecast GOVX's earnings for 2027 to be -$77,939,954, with the lowest GOVX earnings forecast at -$74,883,486, and the highest GOVX earnings forecast at -$80,232,306.
In 2028, GOVX is forecast to generate $279,875,291 in earnings, with the lowest earnings forecast at $268,899,789 and the highest earnings forecast at $288,106,917.